TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Psychiatric |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 6 - 12 |
| Updated: | 7/11/2015 |
| Start Date: | March 2014 |
| End Date: | April 2015 |
TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study
The purpose of this study is to determine whether TRI102-ADD-001 is effective in the
treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6-12.
treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6-12.
Inclusion Criteria:
- Children aged 6 to 12 years with ADHD who require pharmacologic treatment for this
condition
Exclusion Criteria:
- Other serious illnesses or conditions that would put the patient at particular risk
for safety events or would interfere with treatment/assessment of ADHD
We found this trial at
5
sites
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials